Literature DB >> 21686465

Repeated phlebotomies improve and stabilise renal function in cyanotic nephropathy.

Kennedy O Omonuwa1, Arunabh Talwar, Sophy Dedopoulos, Lionel U Mailloux.   

Abstract

Patients over 10 years of age with cyanotic congenital heart disease (CCHD) risk developing significant glomerular proteinuria, a condition called cyanotic nephropathy. Even though the pathogenesis of glomerulopathy associated with CCHD is still unclear, a potential mechanism is hyperviscosity-induced decrease in peritubular capillary blood flow leading to an increase in glomerular capillary pressure, in turn resulting in proteinuria. Although angiotensin-converting enzyme (ACE) inhibitors have been traditionally used in the treatment of these patients with cyanotic nephropathy, they may, however, not be well tolerated. Here we present a case of an adult patient with CCHD who could not tolerate an ACE inhibitor but showed improvement and stabilisation of her renal function following treatment with repeated phlebotomies.

Entities:  

Year:  2009        PMID: 21686465      PMCID: PMC3030262          DOI: 10.1136/bcr.10.2008.1084

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease.

Authors:  J K Perloff; H Latta; P Barsotti
Journal:  Am J Cardiol       Date:  2000-12-01       Impact factor: 2.778

Review 2.  THE GLOMERULUS IN CYANOTIC CONGENITAL HEART DISEASE AND PRIMARY PULMONARY HYPERTENSION. A REVIEW.

Authors:  G S SPEAR
Journal:  Nephron       Date:  1964       Impact factor: 2.847

Review 3.  Secondary polycythaemia: its causes, effects and treatment.

Authors:  B D Harrison; T C Stokes
Journal:  Br J Dis Chest       Date:  1982-10

4.  The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease.

Authors:  P E de Jong; J J Weening; A J Donker; G K van der Hem
Journal:  Nephron       Date:  1983       Impact factor: 2.847

5.  Mechanisms of development and progression of cyanotic nephropathy.

Authors:  Jun Inatomi; Kentaro Matsuoka; Rika Fujimaru; Atsuko Nakagawa; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2006-08-11       Impact factor: 3.714

6.  Effect of congenital heart disease on renal function in childhood.

Authors:  Pinar Isik Agras; Murat Derbent; Figen Ozcay; Esra Baskin; Suna Turkoglu; Derya Aldemir; Kurşat Tokel; Umit Saatci
Journal:  Nephron Physiol       Date:  2005

7.  Abnormal rheology in cyanotic congenital heart disease--a factor in non-immune nephropathy.

Authors:  S Dittrich; K Kurschat; P E Lange
Journal:  Scand J Urol Nephrol       Date:  2001-10

8.  Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.

Authors:  Y Fujimoto; M Matsushima; K Tsuzuki; M Okada; M Shibata; Y Yanase; K Usui; M Nagashima
Journal:  Clin Nephrol       Date:  2002-08       Impact factor: 0.975

9.  Renal involvement in patients with congenital cyanotic heart disease.

Authors:  F Krull; J H Ehrich; U Wurster; U Toel; S Rothgänger; I Luhmer
Journal:  Acta Paediatr Scand       Date:  1991-12

10.  Renal impairment in patients with long-standing cyanotic congenital heart disease.

Authors:  S Dittrich; N A Haas; C Bührer; C Müller; I Dähnert; P E Lange
Journal:  Acta Paediatr       Date:  1998-09       Impact factor: 2.299

  10 in total
  1 in total

1.  Prevalence and associated factors of renal dysfunction and proteinuria in cyanotic congenital heart disease.

Authors:  Nattaphorn Hongsawong; Prapimdaw Khamdee; Suchaya Silvilairat; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2017-10-02       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.